CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells

Molecular Endocrinology

Volumn 11, Issue 9, 1997, Pages 1191-1202

  Teixeira, Christine ^a   Pratt, M A Christine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN P21; PROTEIN P27; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; RETINOIC ACID;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0031461602     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.9.9977     Document Type: Article

References (69)

1. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
2. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
3. Kastner P, Mark M, Chambon P 1995 Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869
4. Gudas LJ 1992 Retinoids, retinoid-responsive genes, cell differentiation and cancer. Cell Growth Differ 3:655-662
5. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL 1992 Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52:2236-2242
6. Van der Burg B, van der Leede B-JM, Kwakkenbos-Isbrucker L, Salverda S, de Kaat SW, van der saag PT 1992 Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91:149-157
7. Pratt MAC, Deonarine D, Teixeira C, Novosad D, Tate B, Grippo J 1996 The AF-2 region of the RARα mediates retinoic acid inhibition of estrogen receptor function in human breast cancer cells. J Biol Chem 271: 20346-20353
8. Demirpence E, Balaguer P, Trousse F, Nicolas J-C, Pons M, Gagne D 1994 Antiestrogenic effects of all-trans retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54:1458-1464
9. Demirpence E, Pons M, Balaguer P, Gagne D 1992 Study of an antiestrogenic effect of retinoic acid in MCF-7 cells. Biochem Biophys Res Commun 183:100-106
10. Liu Y, Lee MO, Wang H-G, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X-K 1996 Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16:1138-1149
11. Sheikh MS, Shao Z-M, Li X-S, Dawson M, Jetten AM, Wu S, Conley BA, Garcia M, Rochefort H, Fontana JA 1994 Retinoid-resistant estrogen-receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-α acquire sensitivity to growth inhibition by retinoids. J Biol Chem 269:21440-21447
12. Marth C, Bock G, Daxenbichler G 1985 Effects of 4-hydroxy-phenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J Natl Cancer Inst 75:871-875
13. Morgan DO 1995 Priniciples of cdk regulation. Nature 374:131-134
14. Norbury C, Nurse P 1992 Animal cell cycles and their control. Annu Rev Biochem 61:441-470
15. Reed SI 1991 G1-specific cyclins: in search of an S phase promoting factor. Trends Genet 7:95-99
16. Sherr CJ 1993 Mammalian G1 cyclins: review. Cell 73:1059-1065
17. Gu Y, Rosenblatt J, Morgan DO 1992 Cell cycle regulation of cdk2 activity by phosphorylation of Thr 160 and Tyr 15. EMBO J 11:3995-4005
18. Matsuoka M, Kato J, Fisher R, Morgan DO, Sherr CJ 1994 Activation of cyclin dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol Cell Biol 14:7265-7275
19. Sebastian B, Kakizuka A, Hunter T 1993 Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci USA 90:3521-3524
20. INK/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2952
21. Hirai H, Roussel MF, Kato J-Y, Ashum RA, Sherr CJ 1995 Novel Ink4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681
22. INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature 371:257-261
23. Serrano M, Hannon GJ, Beach D 1993 A new regulatory motif in the cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707
24. El-Diery WS, Tokino T, Velculescu VE, Levy DB, Parsons JM, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-025
25. Gu Y, Turck CW, Morgan DO 1993 Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710
26. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
27. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649
28. Kip2, a structurally distinct member of the Cip1 cdk inhibitor family is a candidate tumour suppressor gene. Genes Dev 9:650-662
29. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR 1994 Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98
30. Kip1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66
31. Toyoshima H, Hunter T 1994 p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74
32. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J-Y, Livingston DM 1993 Functional interactions of the retinoblastoma protein with mammalian-D-type cyclins. Cell 73:487-497
33. Kato J-Y, Matsaaki M, Strom DK, Sherr CJ 1994 Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol Cell Biol 14:2713-2721
34. PSKJ3/CDK4) for mammalian D-type G1 cyclins. Cell 71:323-334
35. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y 1994 D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
36. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR 1991 The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061
37. Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR 1992 The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6:177-185
38. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T 1992 The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle related manner. Cell 68:157-166
39. Weintraub SJ, Prater CA, Dean DC 1992 Retinoblastoma protein switches the E2F site from a positive to a negative element. Nature 358:259-261
40. Weinberg RA 1995 The retinoblastoma protein and cell cycle control. Cell 81:323-330
41. Fang F, Newport J 1991 Evidence that the G1 -S and the G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66:731-742
42. Tsai L-H, Lees E, Faha B, Harlow E, Riabowol K 1993 The cdk2 kinase is required for the G1-to-S phase transition in mammalian cells. Oncogene 8:1593-1602
43. Guadagno TM, Newport JW 1996 Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84:73-82
44. Fontana JA, Mezu AB, Cooper BN, Miranda D 1990 Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res 50:1997-2002
45. Ueda H, Takenawa T, Millan JC, Gesell MS, Brandes D 1980 The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells. Cancer 46:2203-2209
46. Fontana JA, Nervi C, Shao ZM, Jetten AM 1992 Retinoid antagonism of estrogen-responsive transforming growth factor α and pS2 gene expression in breast carcinoma cells. Cancer Res 52:3938-3945
47. cdc2. EMBO J 12:3123-3132
48. Reynisdottir I, Polyak K, Iavarone A, Massague J 1995 Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGFβ. Genes Dev 9:1831-1845
49. Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR, Reed SI 1994 A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 14:3683-3694
50. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
51. Watts CKW, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL 1995 Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol Endocrinol 9:1804-1813
52. Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M 1994 Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9:2663-2674
53. Wilcken NRC, Sarcevic B, Musgrove EA, Sutherland RL 1996 Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth Differ 7:65-74
54. Gorospe M, Lui Y, Xu Q, Chrest FJ, Holbrook NJ 1996 Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol 16:762-770
55. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496
56. Kip1. Cell Growth Differ 6:915-925
57. Aprelikova O, Xiong X, Lui ET 1995 Both p16 and p21 families of cyclin-dependent kinase (cdk) inhibitors block the phosphorylation of cyclin dependent kinases by the cdk-activating kinase. J Biol Chem 270: 18195-18197
58. Foster JS, Wimalasena J 1996 Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol 10:488-498
59. Shiffman D, Brooks EE, Brooks AR, Chan CS, Milner PG 1996 Characterization of the human cyclin-dependent kinase 2 gene. J Biol Chem 271:12199-12204
60. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman R, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
61. Sebastian B, Kakizuka A, Hunter T 1993 Cdc25M2 activation of cyclin dependent kinases by dephosphorylation of threonin-14 and tyrosine-15. Proc Natl Acad Sci USA 90:3521-3524
62. Yamashita K, Yasuda H, Pines J, Yasumoto K, Nishitani H, Ohtsubo M, Hunter T, Sugimura T, Nishimoto T 1990 Okadaic acid, a potent inhibitor of type I and type 2A protein phosphatases, activates ada2/H1 kinase and transiently induces a premature mitosis-like state in BHK21 cells. EMBO J 9:4331-4338
63. cdk2 is a component of the E2F-cyclin A complex. Cell 68:167-176
64. Xu M, Sheppard K-A, Peng C-Y, Yee AS, Piwnica-Worms H 1994 Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA binding activity of E2F/DP-1 by phosphorylation. Mol Cell Biol 14:8420-8431
65. Dynlacht BD, Flores O, Lees JA, Harlow E 1994 Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8:1771-1786
66. Krek W, Xu G, Livingston DM 1995 Cyclin-A kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158
67. Auffray C, Rougeon F 1980 Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107:303-314
68. Doucet JP, Murphy BJ, Tuana BS 1993 A highly porous SDS gel electrophoresis system: a versatile technique for protein structure-function study. Methods Pharmacol 7:237-254
69. Tassan JP, Schultz SJ, Bartek J, Nigg EA 1994 Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J Cell Biol 127:467-478